Endpoints News
What Ngai heard from health tech investors in Boston Read in browser
Endpoints News
Thursday, 30 April 2026
Thank you for reading, dupa dupackia!
basic
UPGRADE
ENDPOINTS at #ASCO26
ASCO is about to deliver some make-or-break cancer data. Join us to figure out which pipeline bets will pay off. Get your spot now.
Notes from Boston
I just came back from the Digital Healthcare Innovation Summit in Boston earlier this week, where I got a good look into what investors are thinking about. A few impressions:
  • Investors see a future where AI takes care of almost every part of the healthcare experience. The idea is that AI will inevitably tackle every step: intake, ordering tests, reviewing results, drafting a diagnosis plan, writing scripts and scheduling follow-ups. It will escalate to human staff and clinicians only when necessary. The people I spoke to disagreed only on when that will happen, given the regulatory and payment challenges.

  • Funding for AI to tackle healthcare operations (as we discussed Tuesday) continues to be hot. What investors are struggling to figure out, though, is whether a single company that does everything for everyone across healthcare wins out, or whether it's better to invest in all-in-one tools built for specialties, such as oncology.

  • Consumer behavior feels like it has the power to shape health tech more than ever. We’ve already seen the huge demand for GLP-1 weight-loss drugs and the boom of telehealth companies selling compounded versions. But patients are also turning to mental health chatbots for 24/7 care, uploading health records to ChatGPT and bringing their wearables data to their medical appointments. I’m seeing businesses being built around these shifts.

  • Lots of companies are repositioning themselves as longevity companies, from concierge medicine practices to consumer wearable devices and virtual care.
We’ll be unpacking some of these themes at the Financial Times' US Pharma and Biotech Summit, held in partnership with Endpoints News, in NYC on May 14 - check out the agenda here. Hope to see you there!
- Ngai

P.S. - Exciting news! Shelby's reporting on compounding pharmacy giant Empower Pharmacy won a NIHCM award! Congratulations, Shelby! And thanks to everyone who read her award-winning piece. Check out the impressive list of winners here.
Here’s what’s new
CVS' healthcare delivery chief eyes potential in clinical AI
CVS Health has been test­ing AI tools that de­liv­er health­care, though it sees too many bar­ri­ers to us­ing them more wide­ly for now.
Should pharma be swinging bigger with AI? One top researcher left Genentech so he could try
Kyunghyun Cho says he left big pharma after almost five years – despite the support of his company’s leadership – because he thinks the industry doesn’t dream big enough.
Admin AI’s reign
A chart shows the number of early deals by quarter for AI healthcare administrative startups.
The number of seed and Series A deals for healthcare admin tech startups have continued to climb over the past few years, according to data from Rock Health. In the first quarter of this year, these deals accounted for 6.9% of total digital health venture funding.
This week in health Тech

Hinge Health is adding migraine care services, expanding the company’s reach beyond virtual musculoskeletal services to neurology. The migraine care program includes Hinge’s Enso device for nerve stimulation, an app and access to a care team.

“We’re constantly looking for opportunities where technology maturity is at a point to where we could peel away an aspect of in-person care or a care journey, and we can use technology to automate a meaningful portion of that care,” CEO Dan Perez told us. Perez said the company is looking for other opportunities beyond physicial therapy and migraine care.

Health system CEOs defended their prices at a congressional hearing on healthcare affordability Tuesday, instead blaming health insurer policies, sicker patients, expensive supplies, and administrative and regulatory burdens for the rising cost of their services.

In particular, the CEOs from HCA Healthcare, CommonSpirit Health, New York-Presbyterian and ECU Health said hospitals should be paid more for the same procedures than when they are delivered at physician offices.

“There are aspects to hospitals that reimbursement covers beyond just the procedure and that’s 24/7, 365 readiness” as well as disasters and uncompensated care, HCA CEO Sam Hazen said. He conceded that there are some instances where the gaps between hospital and surgery center prices are too wide.

Humana’s fleet of primary care centers is growing rapidly. The insurer owned or co-owned 398 primary care centers as of March 31, a sharp increase from 329 a year ago, it reported as part of its first-quarter results Wednesday. The growth mostly stems from its acquisition of Florida chain MaxHealth. This year, Humana will have the option to purchase some jointly owned clinics for $1 billion to $1.5 billion.
OpenEvidence appears to be no longer available in the UK and Europe. Screenshots posted show the AI medical search tool citing uncertainty about how AI systems are treated there.
Clinical AI startup Aidoc raised $150 million. Goldman Sachs led the Series E round, which came just nine months after the company raised $150 million for its healthcare foundation model.
Endpoints News
2029 Becker Drive; Lawrence, Kansas 66047 USA Privacy and deletion: help@endpointsnews.com
web twitter linkedin
Worldwide made. Thanks for reading.
Unsubscribe preferences
Unsubscribe from all newsletters
FT Specialist Logo A service from the Financial Times